•Sales increased by 18% to 208.1 (176.0) MSEK •Operating income amounted to -29.1 (14.0) MSEK •Net income amounted to -17.5 (2.7) MSEK (the operating income and net sales for the period includes non-recurring costs of 44.8 (0) MSEK) •Order intake amounted to 24 (29) systems •15 (16) EBM systems were delivered in the fourth quarter
Significant events after the end of the period: •The company has called for an extraordinary general meeting on February 7, 2017 at 4 pm (CET). •The company has received an unconditional shareholder contribution of 16.9 MSEK.
I'm interested to hear the details of the last bullet point. 16.9 MSEK ~ $1.90 million USD. Hopefully we'll hear something later today.
I have a progression of images in my head that I can't shake.
AP&C seems to be growing and expanding at leaps and bounds. AP&C hires new people. One of the new employees says "I can afford a dog." The employee gets lovable mutt from a shelter. The employee and dog both eat well. The dog takes a dump in the yard. A fly lands on the yard deposit for it's meal.
Who is the bigger Arcam stakeholder, the fly or a person with no shares in the company?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.